ランキング価格はじめての方へ
  1. 米国企業
  2. CVS HEALTH Corp
  3. Raw

CVS HEALTH CorpCVS

時価総額
$989.7億
PER
保険・ヘルスサービスとPBM、調剤・小売薬局の米国最大手。AI・機械学習を活用した処方管理システムや価値基盤の診療支援プラットフォームを展開。2023年に主要医療提供資産を2件で買収、同年にバイオシミラー事業子会社を設立。米国中心に小売店舗9,000店超、30日換算で19億件の処方管理を実施。
概要財務
サマリーテーブルに戻る
2010年
12月31日		2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日		2024年
12月31日
Proceeds from Customers-97,688113,205114,993132,406148,954172,310176,594186,519248,393264,327284,219313,662345,464357,995
Cash paid for inventory, prescriptions dispensed and health services rendered--------148,821---189,766208,848197,726
Insurance benefits paid--------7,057---69,72884,097109,464
Cash paid to other suppliers and employees13,77813,63513,64314,29515,34414,16215,55015,34817,23428,93229,76331,65232,66234,73538,821
Interest and investment income received--------6449558947431,0261,5841,735
Interest paid-------1,0722,8032,9542,9042,4692,2392,4182,909
Income taxes paid-------2,9092,3832,7172,9293,1954,1163,5241,703
Net cash provided by operating activities4,7795,8566,6715,7838,1378,41210,0698,0078,86512,84815,86518,26516,17713,4269,107
Proceeds from sales and maturities of investments--------8177,0496,4677,2466,7297,72910,353
Purchases of investments--------6927,5349,6399,9637,7469,04315,191
Purchases of property and equipment2,0051,8722,0301,9842,1362,3672,2241,9182,0372,4572,4372,5202,7273,0312,781
Acquisitions (net of cash and restricted cash acquired)1771,4413784152,43911,4755391,28742,22644486614613916,61295
Proceeds from Divestiture of Businesses, Net of Cash Divested--------832-840--1,249--
Other---------21-42--122-85-68-101
Net cash used in investing activities-1,640-2,410-1,849-1,835-4,045-13,420-2,470-2,932-43,285-3,339-5,534-5,261-5,047-20,889-7,613
Commercial paper borrowings (repayments), net-------------2001,919
Proceeds from Other Short-Term Debt-------------5,000-
Repayment of short-term loan-------------5,000-
Proceeds from issuance of long-term debt9911,4631,2393,9641,48314,8053,455-44,3433,7369,958987-10,8987,913
Repayments of long-term debt2,1032,1221,718-3,1002,9025,943-5,5228,33615,63110,2544,2113,1664,773
Repurchase of common stock1,5003,0014,3303,9764,0015,0014,4614,361----3,5002,0123,023
Dividends paid4796748291,0971,2881,5761,8402,0492,0382,6032,6242,6252,9073,1323,373
Proceeds from Stock Options Exercised285431836500421299224329242210264549551277361
Payments for taxes related to net share settlement of equity awards-------719711288168370181185
Other--9----3-5-11--27155-79-20126
Net cash provided by (used in) financing activities-2,798-3,460-4,860-1,237-5,6945,006-6,689-6,75136,819-7,850-8,155-11,356-10,5162,683-1,135
Net increase (decrease) in cash, cash equivalents and restricted cash--------2,3951,6592,1761,648614-4,780359
Net income3,4243,4573,8754,5924,6445,2395,3196,623-5966,6317,1927,8984,1658,3684,586
Depreciation and amortization-------2,4792,7184,3714,4414,5124,2474,3664,597
Loss on assets held for sale------------2,533349-
Stock-based compensation150135132141165230222234280453400484447588540
Restructuring Costs, Asset Impairment Charges--------------840
Gain on sale of subsidiaries------------475--
Gain on early extinguishment of debt---348--521--643---79-1,440-452--491
Deferred income taxes--------87-654-570-428-2,075-676-572
Other items--------53-339-264-72390-332-416502
Accounts receivable, net-5327483872,2107371,5942439411,1392,1581,5102,7032,9716,2601,301
Inventories352-607858-127701,1417425141,1531,075973-7351,435-1,233102
Other assets-4999135-9-243-3-614-364356651038
Increase (Decrease) in Accounts Payable-401,1281,1471,0241,7422,8342,1891,7102,4893,5502,7692,8984,2603,6182,335
Increase (Decrease) in Insurance Liabilities---------471320-2311691,2473942,757
Other liabilities----13-1042381651,4762,7402,8526,4681,540-3,542
Net cash provided by operating activities4,7795,8566,6715,7838,1378,41210,0698,0078,86512,84815,86518,26516,17713,4269,107